Corteva, Inc. (CTVA)

NYSE • Currently down 0.43 (-0.56%) in today's trading session

1 member of Congress has disclosed 3 trades in Corteva, Inc. (CTVA) via STOCK Act filings. The most recent disclosure was a sale by Gilbert Cisneros on 6 December 2019. Aggregate disclosed activity totals roughly $8K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Corteva, Inc. is currently trading at $77.03, positioned at 66% of its 52-week range ($60.53 – $85.63).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$77.03
24h Change
-0.43 (-0.56%)
52 Week Range
$60.53—$85.63
View on NASDAQ

Corteva, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for CTVA

Select to highlight on chart
3 transactions
Compliance: 100%
Gilbert Cisneros6 Dec 201910 Jan 2020SaleStock$1,001 - $15,000N/A
Gilbert Cisneros14 Aug 201911 Sept 2019PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros3 Jun 201912 Jul 2019Stock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$51.52B

Volume

3.34M

Beta

0.57

P/E Ratio

41.64

Fundamentals

EPS

$1.85

Div. Yield

0.93%

Open

$77.46

Day Range

$76.53 — $78.60

Company Information

Sector
Basic Materials
Industry
Agricultural Inputs
Exchange
NYSE · USD
Country
US
CEO
Charles Victor Magro
IPO Date
2019-05-24
Website
www.corteva.com

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies th...

Earnings

Next Report

Q2 2026

30 Jul

EPS Est.

$2.23

Rev. Est.

$6.6B

Days Until

52

Recent Quarters

Q1 20265 May
EPS$1.50
Beat 28.2%
Q4 20253 Feb
EPS$0.22
Miss 1.3%
Q3 20254 Nov
EPS$-0.23
Beat 54.6%
Q2 20256 Aug
EPS$2.20
Beat 16.4%
Q1 20257 May
EPS$1.13
Beat 29.3%
Q4 20245 Feb
EPS$0.32
Beat 2.5%
Q3 20246 Nov
EPS$-0.49
Miss 61.7%
Q2 202431 Jul
EPS$1.83
Beat 5.8%
Q1 20241 May
EPS$0.89
Beat 8.1%
Q4 202331 Jan
EPS$0.15
Beat 155.4%
Q3 20238 Nov
EPS$-0.23
Beat 11.5%
Q2 20233 Aug
EPS$1.60
Beat 1.3%
Q1 20233 May
EPS$1.16
Beat 24.7%
Q4 20221 Feb
EPS$0.16
Beat 166.7%
Q3 20223 Nov
EPS$-0.12
Beat 47.8%
Q2 20224 Aug
EPS$1.64
Beat 12.3%
Q1 20224 May
EPS$0.97
Beat 18.3%
Q4 20212 Feb
EPS$0.08
Beat 0.0%
Q3 20213 Nov
EPS$-0.14
Beat 57.6%
Q2 20215 Aug
EPS$1.40
Beat 11.1%
Q1 20214 May
EPS$0.79
Beat 21.5%
Q4 20203 Feb
EPS$0.04
Beat 180.0%
Q3 20204 Nov
EPS$-0.39
Beat 7.1%
Q2 20205 Aug
EPS$1.26
Beat 1.6%
Q1 20206 May
EPS$0.59
Beat 51.3%
Q4 201930 Jan
EPS$0.07
Beat 158.3%
Q3 201931 Oct
EPS$-0.39
Beat 15.2%
Q2 20191 Aug
EPS$1.42
Beat 42.0%
Q1 201931 May
EPS$0.22
Q4 201819 Mar
EPS$-6.83
Q3 201831 Dec
EPS$-0.61
Q1 201830 Jun
EPS$0.93
Q4 201731 Mar
EPS$-0.29
Q3 201731 Dec
EPS$2.94
Q2 201730 Sept
EPS$-1.13
Q1 201730 Jun
EPS$0.79
Q4 201631 Mar
EPS$0.79

Dividends

Dividend History

1 Jun 2026
Amount $0.1800
2 Mar 2026
Amount $0.1800
1 Dec 2025
Amount $0.1800
2 Sept 2025
Amount $0.1800
2 Jun 2025
Amount $0.1700
3 Mar 2025
Amount $0.1700
2 Dec 2024
Amount $0.1700
3 Sept 2024
Amount $0.1700
4 Jun 2024
Amount $0.1600
29 Feb 2024
Amount $0.1600
30 Nov 2023
Amount $0.1600
31 Aug 2023
Amount $0.1600
31 May 2023
Amount $0.1500
28 Feb 2023
Amount $0.1500
10 Nov 2022
Amount $0.1500
11 Aug 2022
Amount $0.1500
12 May 2022
Amount $0.1400
28 Feb 2022
Amount $0.1400
10 Nov 2021
Amount $0.1400
12 Aug 2021
Amount $0.1400
13 May 2021
Amount $0.1300
26 Feb 2021
Amount $0.1300
12 Nov 2020
Amount $0.1300
13 Aug 2020
Amount $0.1300
14 May 2020
Amount $0.1300
2 Mar 2020
Amount $0.1300
27 Nov 2019
Amount $0.1300
30 Jul 2019
Amount $0.1300

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about CTVA

Which members of Congress have traded CTVA?
1 member of Congress has disclosed 3 trade in Corteva, Inc. (CTVA) under the STOCK Act: Gilbert Cisneros.
When was CTVA most recently disclosed by Congress?
The most recent CTVA disclosure was a sale by Gilbert Cisneros on 6 December 2019.
What is the total disclosed congressional trading volume for CTVA?
Members of Congress have disclosed approximately $8K in CTVA purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in CTVA?
This CTVA page updates as soon as new STOCK Act disclosures are filed for Corteva, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.